Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions
http://ghr.nlm.nih.gov/     A service of the U.S. National Library of Medicine®

LIPA

Reviewed October 2007

What is the official name of the LIPA gene?

The official name of this gene is “lipase A, lysosomal acid, cholesterol esterase.”

LIPA is the gene's official symbol. The LIPA gene is also known by other names, listed below.

What is the normal function of the LIPA gene?

The LIPA gene provides instructions for making an enzyme called lysosomal acid lipase. This enzyme is found in the lysosomes (compartments that digest and recycle materials in the cell), where it breaks down fats (lipids) such as cholesteryl esters and triglycerides.

In the body, cholesterol works with high-density lipoproteins (HDL), often referred to as "good cholesterol." High-density lipoproteins carry cholesterol from the body's tissues to the liver for removal. When the cholesterol is attached to a fatty acid it is a cholesteryl ester. Normally, the cholesteryl esters are broken down by lysosomal acid lipase into cholesterol and a fatty acid and then excreted or used by the body as nutrients.

How are changes in the LIPA gene related to health conditions?

cholesteryl ester storage disease - caused by mutations in the LIPA gene

More than 20 mutations in the LIPA gene have been found to cause cholesteryl ester storage disease. Most of these mutations change single amino acids in lysosomal acid lipase and decrease the protein's functional ability.

The most common LIPA mutation that causes cholesteryl ester storage disease disrupts how genetic information is spliced together to make the blueprint for producing lysosomal acid lipase. This particular mutation, called a splice-site mutation, substitutes the nucleotide guanine for the nucleotide adenine near an area of the gene called exon 8 (written as IVS8-1G>A). (Nucleotides are the building blocks of DNA.) This mutation disrupts the way the gene's instructions are used to make the enzyme, resulting in a deletion of 24 building blocks of protein (amino acids). People with the IVS8-1G>A mutation in both copies of the LIPA gene in each cell have only 5 percent of the normal amount of liposomal lipase activity.

Decreased lysosomal acid lipase activity leads to an accumulation of cholesteryl esters and triglycerides in the cells and tissues throughout the body, particularly the heart and liver. In general, lower lysosomal acid lipase activity results in more severe disease.

Wolman disease - caused by mutations in the LIPA gene

More than 10 mutations in the LIPA gene have been found to cause Wolman disease. Most of these mutations result in the production of an abnormally short version of lysosomal acid lipase, which does not function properly.

The lack of lysosomal acid lipase activity results in an accumulation of cholesteryl esters and triglycerides in the cells and tissues of the spleen, liver, bone marrow, small intestine, adrenal glands, and lymph nodes. This accumulation as well as malnutrition caused by the body's inability to use lipids properly result in the signs and symptoms of Wolman disease.

Where is the LIPA gene located?

Cytogenetic Location: 10q23.2-q23.3

Molecular Location on chromosome 10: base pairs 89,213,568 to 89,252,038

The LIPA gene is located on the long (q) arm of chromosome 10 between positions 23.2 and 23.3.

The LIPA gene is located on the long (q) arm of chromosome 10 between positions 23.2 and 23.3.

More precisely, the LIPA gene is located from base pair 89,213,568 to base pair 89,252,038 on chromosome 10.

See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genelocation) in the Handbook.

Where can I find additional information about LIPA?

You and your healthcare professional may find the following resources about LIPA helpful.

You may also be interested in these resources, which are designed for genetics professionals and researchers.

What other names do people use for the LIPA gene or gene products?

  • CESD
  • cholesterol ester hydrolase
  • LAL
  • LICH_HUMAN
  • lipase A
  • lipase A, lysosomal acid, cholesterol esterase (Wolman disease)
  • lysosomal acid lipase
  • sterol esterase

See How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.

What glossary definitions help with understanding LIPA?

acids ; adenine ; adrenal glands ; bone marrow ; cell ; cholesterol ; deletion ; DNA ; enzyme ; esters ; exon ; gene ; guanine ; HDL ; hydrolase ; intestine ; lipase ; lymph ; mutation ; nucleotide ; protein ; splice-site mutation ; triglycerides

You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://www.ghr.nlm.nih.gov/glossary).

References

  • Anderson RA, Bryson GM, Parks JS. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. Mol Genet Metab. 1999 Nov;68(3):333-45. (http://www.ncbi.nlm.nih.gov/pubmed/10562460?dopt=Abstract)
  • Anderson RA, Byrum RS, Coates PM, Sando GN. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2718-22. (http://www.ncbi.nlm.nih.gov/pubmed/8146180?dopt=Abstract)
  • Anderson RA, Rao N, Byrum RS, Rothschild CB, Bowden DW, Hayworth R, Pettenati M. In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3. Genomics. 1993 Jan;15(1):245-7. (http://www.ncbi.nlm.nih.gov/pubmed/8432549?dopt=Abstract)
  • Aslanidis C, Klima H, Lackner KJ, Schmitz G. Genomic organization of the human lysosomal acid lipase gene (LIPA). Genomics. 1994 Mar 15;20(2):329-31. (http://www.ncbi.nlm.nih.gov/pubmed/8020990?dopt=Abstract)
  • Mayatepek E, Seedorf U, Wiebusch H, Lenhartz H, Assmann G. Fatal genetic defect causing Wolman disease. J Inherit Metab Dis. 1999 Feb;22(1):93-4. (http://www.ncbi.nlm.nih.gov/pubmed/10070628?dopt=Abstract)
  • NCBI Gene (http://www.ncbi.nlm.nih.gov/gene/3988)
  • Pagani F, Pariyarath R, Garcia R, Stuani C, Burlina AB, Ruotolo G, Rabusin M, Baralle FE. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J Lipid Res. 1998 Jul;39(7):1382-8. (http://www.ncbi.nlm.nih.gov/pubmed/9684740?dopt=Abstract)
  • Zschenker O, Jung N, Rethmeier J, Trautwein S, Hertel S, Zeigler M, Ameis D. Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease. J Lipid Res. 2001 Jul;42(7):1033-40. (http://www.ncbi.nlm.nih.gov/pubmed/11441129?dopt=Abstract)

 

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

 
Reviewed: October 2007
Published: November 24, 2014